What's at Stake in the Fight Against Monkeypox
There’s still time for a forceful global response to shape the future of the disease.
Stay updated with breaking news from Special Pathogens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
There’s still time for a forceful global response to shape the future of the disease.
Rate as high as 10%. dr louise ivers, is the director of the center for global health at massachusetts general hospital, where a patient is currently being treated for monkeypox? how is the patient doing how is the patient being treated? the how is the patient doing how is the patient being treated?— patient being treated? the patient is re orted patient being treated? the patient is reported to _ patient being treated? the patient is reported to be _ patient being treated? the patient is reported to be doing _ patient being treated? the patient is reported to be doing well. i i patient bein...
We can now speak to dr syra madad wh's an infectious disease specialist and the special pathogens program senior director at nyc health and hospitals.. thank you very much for being with theirs. as he mentioned there, he has said it is time to return to normality. how do you feel about that? i to return to normality. how do you feel about that?— you feel about that? i mean, they are _ you feel about that? i mean, they are all _ you feel about that? i mean, they are all ready _ you feel about that? i mean, they are all ready to - you feel about that? i mean, they are all ready to return i you...
TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...
TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“ Theralase® ” or the “ Company ”) ( TSXV: TLT ) ( OTCQB: TLTFF ), a clinical stage…